7th September 2021 | Pharma Updates
EXIM Bank engages with Indian Drug Companies
Export-Import Bank of India, Japan Bank for International Cooperation and Pharmaceutical Export Promotion Council of India organized a webinar on ‘Innovative Funding Structures and Assistance for Manufacturers of Covid related Pharma Products’.
Hetero Pharma gets EUA from India’s Drug Regulator for Tocilizmab
The Drug Controller General of India has issued Emergency Use Authorisation for the generic version of Tocilizumab in India. It will be marketed by Hetero Healthcare.
Mankind Pharma Provides Funds to the Youngest Boy Aiming To Reach Everest Base Camp
The drug company will provide financial aid to Heyansh and his family members with a sum of Rs 10 Lakh.
MGC Pharma takes final move towards EUA for its Covid treatment in India
The drug company has received a nod from the Indian authorities to import its phytomedicine CimetrA in India as a final move towards obtaining emergency use authorisation for the treatment of Covid patients.
Alembic Pharma gets FDA approval for Metronidazole Gel
The pharma firm has received a final rod from US FDA for Metronidazole Gel.
Zydus receives approval for Sitagliptin base tablets
Zydus’s Sitagliptin base 25, 50 and 100 milligram tablets has received tentative approval from the US FDA.
National Pharmacovigilance Week begins from Sept 17-23
The theme for 2021 is “Pharmacovigilance: A step towards Patient Safety”.